Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Cost of Revenue (2022 - 2025)

Historic Cost of Revenue for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to $405000.0.

  • Envoy Medical's Cost of Revenue rose 279.19% to $405000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 503.18%. This contributed to the annual value of $1.7 million for FY2024, which is 408.16% up from last year.
  • According to the latest figures from Q3 2025, Envoy Medical's Cost of Revenue is $405000.0, which was up 279.19% from $361000.0 recorded in Q2 2025.
  • In the past 5 years, Envoy Medical's Cost of Revenue ranged from a high of $538000.0 in Q4 2022 and a low of $106000.0 during Q3 2022
  • Over the past 4 years, Envoy Medical's median Cost of Revenue value was $394000.0 (recorded in 2024), while the average stood at $397538.5.
  • Per our database at Business Quant, Envoy Medical's Cost of Revenue surged by 27641.51% in 2023 and then crashed by 2736.42% in 2025.
  • Envoy Medical's Cost of Revenue (Quarter) stood at $538000.0 in 2022, then fell by 4.65% to $513000.0 in 2023, then increased by 0.97% to $518000.0 in 2024, then dropped by 21.81% to $405000.0 in 2025.
  • Its Cost of Revenue stands at $405000.0 for Q3 2025, versus $361000.0 for Q2 2025 and $358000.0 for Q1 2025.